He is an Advisory Council Member of the Breast International Group (BIG) as well as member of BIG-North American
Breast Cancer Group (BIG-NABCG) and Drafting Committee Member of Consent Guidelines for Biorepository. He is
the member of the American School of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO) where
he is the member of ESMO Global Policy Committee, Global Cancer Task Force Member, ESMO Coordinator for ESMO
Global Opioid Policy Initiative member and Member ESMO-EAPC Joint Executive Committee.
He is the Chairman of the International Society of Geriatric Oncology SIOG Publication Committee. He is also a member
of the SIOG Governance Council and Member of SIOG Task Force on Bone Protection. He is Editorial Board Member of
Journal of Thoracic Oncology (JTO), Journal of Geriatric Oncology, Critical Reviews in Oncology/ Hematology (CROH),
Journal of Global Oncology–ASCO, Journal of Annals of Translational Medicine. He has special interest in Palliative
Care and Geriatric Oncology. He has been a Reviewer for 2014 HOPA Research Grant. He is Reviewer for UICC
Seeding Progress and Resources for the Cancer Community (SPARC) Grants Project. He has been awarded Certificate
of recognition for Promotion and Development of Palliative Care in the World in 2013, by International Association for
Hospice & Palliative Care (IAHPC). He is the Executive Council Member of International Cardi-Oncological Society
(ICOS). He is the member of the Steering Committee of World Health Organization (WHO) for Oncology. He has also
received the Accreditation – 2015 ESMO Designated Centre of Integrated Oncology and Palliative Care.
• Member Indian Council of Medical Research (ICMR) Task Force for Management of cancer (Govt. of India)
• Chairman Task Force (ICMR) for CLL and Low Grade cancer (Govt. of India)
• National Cancer Control Program (Govt. of India)
• Advisory Board Member to Drug Controller General of India (DCGI), (Govt. of India)
• Faculty Member to Clinical Development Services Agency (CDSA) and Department of Biotechnology (DBT) (Govt. of India)
• NCI-NIH, USA – Task Force Member for Gastro-intestinal cancer and Hepato-biliary cancer
He has published more than 200 papers and has been an Investigator for more than 50 Phase II and III Clinical Trials
done including Translational Research in India.
He is holder of Orphan Drug status with FDA for Hepato-cellular carcinoma, Pancreatic Cancer and Glioma based on
Investigator initiated trials.
He has been conferred with:
• Dr. Farooq Abdullah Oration Award, Jaipur, INDIA – 2014
• Fellow of Academy of European Society for the Translational Medicine (EUSTM).
• Fellow of the American Society for Pharmacology and Experimental Therapeutics (ASPET).
• Associate of Royal College of Obstetricians and Gynecologists (RCOG Associate).
• Recognition Certification for promotion of development of palliative care in the world – International Association for
Hospice & Palliative Care (IAHPC).
Speaker Abstract(s): S02
Hospital of Prato, Department of Medical Oncology, Prato, Italy
Dr. Laura Biganzoli is the Director of the Breast Centre at the Hospital of Prato, Istituto Toscano Tumori, Prato, Italy
She earned her medical degree at the University of Pavia, Italy, and completed fellowships at the National Cancer
Institute of Milan and at the Jules Bordet Institute in Brussels. For five years she worked as a senior staff member at
the Medical Oncology Clinic of the Jules Bordet Institute. From 2009 to 2011 Dr Biganzoli was Visiting Senior Lecturer
in the Division of Cancer Studies at the School of Medicine, King’s College - London
She is board certified in medical oncology and internal medicine.
Dr. Biganzoli was the Director of the European Organization for Research and Treatment of Cancer (EORTC)
Investigational Drug Branch for Breast Cancer, dedicated to the conduction of early phase II studies in advanced breast
cancer, for five years and sat on the Board of Directors of the Breast International Group (BIG) from 1999 to 2003.
Dr. Biganzoli is an active member in different national and international societies, including the International Breast
Cancer Study Group (IBCSG), the American Society of Clinical Oncology (ASCO), the European Society of Medical
Oncology (ESMO), the International Society of Geriatric Oncology (SIOG) and the European Society of Breast Cancer
Dr. Biganzoli has been a member of the EUSOMA Executive Committee since 2011 and ESMO Faculty Member for the
Elderly since 2012. She is part of the SIOG Science & Educational Committee. Dr Biganzoli is Eusoma president-elect.
Her current research focuses on breast cancer and geriatric oncology and she has extensively published in these fields.
Head and Neck Medical Oncology
Paolo Bossi, MD, Medical Oncologist of Head and Neck Cancer Department at the Istituto Nazionale Tumori in Milan,
Italy, is involved in all institutional research activities on head and neck cancer, from translational research (gene
expression, next generation sequencing) to assessment of quality of life and value based medicine.
He has a strong commitment to supportive care, being principal investigator and co-investigator of several Italian and
International trial on Head and Neck cancer, on quality of life and supportive care.